 Eagle Pharmaceuticals Inc NASDAQ: EGRX has agreed to acquire Acacia Pharma Group plc for approximately 94.7 million, equivalent to 0.90 per share. Each shareholder of Acacia Pharma would receive, as consideration for each share of Acacia Pharma held by such shareholder. 